Posted 4/5/2024, 2:05:00 PM
Johnson & Johnson to Acquire Shockwave Medical for $13 Billion, Expanding Cardiovascular Portfolio
- Johnson & Johnson is acquiring Shockwave Medical for $13.1 billion to expand into higher-growth markets
- Shockwave uses intravascular lithotripsy (IVL) to treat calcified arteries without debris breaking loose
- The deal values Shockwave shares at $355 each and is expected to close in mid-2024
- Adding Shockwave builds on J&J's cardiovascular device expertise from recent Abiomed and Laminar deals
- Analyst says fair price offered for Shockwave and doesn't expect antitrust issues or a higher bid
